As we move forward, we are confident that our collective efforts will continue to make significant contributions to the fields of pain and addiction research. Thank you for your continued dedication and support. Together, we are making a difference. | |
|
Thank you to PARC’s donors!
Our donors support our mission to accelerate the translation of research into improved patient care in the areas of pain and addiction. Their gifts provide for the PARC research fellowship annually and enable us to host research symposia and seminars on cutting edge topics. Patient needs in these areas are great and we are grateful for their generosity.
| |
|
PARC FELLOW SPOTLIGHT
Tommaso Di Ianni, PhD
Departments of Psychiatry & Behavioral Sciences and Radiology & Biomedical Imaging
| | |
|
Dr. Di Ianni's research is entitled, “Circuit mechanisms of opioid-mediated responses to subanesthetic ketamine.” Sub-anesthetic ketamine has gained much recent attention as a treatment for neuropsychiatric disorders including major depression, obsessive-compulsive disorder, and chronic pain. However, we still lack a complete understanding of ketamine’s mechanism of action, and recent evidence links ketamine's efficacy to activation of the opioid receptors in key regions of the brain's reward system. In this project, we will use a highly sensitive neuroimaging modality, functional ultrasound imaging, to quantify brain-wide interactions between subanesthetic ketamine and opioid receptors and to determine how these interactions modulate and are modulated by the reward system in a rodent model. | |
|
PARC IN THE NEWS
Recent selected accolades and publications from PARC faculty members
-
Janet Ho, MD, MPH received the Rosalind Franklin Society Award in Science that recognizes and celebrates the contributions of outstanding women in the life sciences and affiliated disciplines for the paper, “Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine,” published in the Journal of Palliative Medicine in 2023.
-
Zheyun Xu, Man-Cheung Lee, Kayla Sheehan, Keisuke Fujii, Katalin Rabl, Gabriella Rader, Scarlett Varney, Manohar Sharma, Helge Eilers, Kord Kober, Christine Miaskowski, Jon D. Levine and Mark A. Schumacher. (2024) Chemotherapy for pain: reversing inflammatory and neuropathic pain with the anticancer agent mithramycin A. Pain 165(1):54–74.
___________________________________________________________
Want to be featured in an upcoming newsletter?
Email us or click here to share awards and recent work!
| | |
SAVE THE DATE
IASP 20th World Congress on Pain
Amsterdam, Netherlands, August 5-9, 2024
International Conference on Opioids
Stockholm, Sweden,
July 15-16, 2024
Innovations in Addiction Medicine and Science
American Society of Addiction Medicine
Denver, CO,
April 24-27, 2025
Register Sept. 2024
| |
|
FAREWELL TO OUR INTERN
PARC would like to thank our research intern, Jason Luo, an undergraduate at Vanderbilt University, for his contributions in 2023-2024. His positive energy and dedication to improving the lives of people with pain and addiction have helped make a difference for the PARC team. We wish him well with his upcoming MCAT and know he will go far!
| | |
2024 PARC SEMINARS
We had an incredible lineup of guest speakers last academic year. If you couldn't join us in person, check them out below. And stay tuned for the first PARC seminar of the new academic year on September 25th. If you'd like to present or have topics you'd like to see, let us know.
| | | | |